Professor Aladdin Mohammad, MD, MPH, PhD, is a Swedish board-certified specialist in rheumatology and internal medicine. He also holds a PhD in medical nephrology and a Master of Public Health with a major in epidemiology. He works as a senior consultant in rheumatology at the Department of Rheumatology, Skåne University Hospital, and as Adjunct Professor at Lund University, Sweden. He also holds a part-time position as Visiting Researcher at the Department of Medicine, University of Cambridge, UK.

Professor Mohammad’s research focuses on clinical, epidemiological, and outcome studies in systemic vasculitis. He has conducted extensive studies on the epidemiology of systemic vasculitis in Southern Sweden, including ANCA-associated vasculitis (AAV), polyarteritis nodosa, Behçet’s disease, giant cell arteritis (GCA), Takayasu’s arteritis, hypocomplementemic urticarial vasculitis, and pediatric vasculitis. His current research particularly addresses comorbidities and long-term outcomes in systemic vasculitis. He is also one of the founding investigators of FAIRVASC, a multinational collaborative project integrating data from six European vasculitis registries to study phenotypes and disease clusters in AAV.

He currently chairs the Swedish national working group for treatment guidelines in AAV and the regional working group for the GCA care pathway. He previously chaired the national task force that developed the standardized care pathway for GCA and was a member of the Swedish national task force that issued the first Swedish Society of Rheumatology treatment guideline for GCA. In addition, he serves as principal investigator for the Fast Track Clinic for suspected GCA at Skåne University Hospital in Lund. From 2019 to 2022, he also served as Associate Editor of the Scandinavian Journal of Rheumatology.

Professor Mohammad is a member of the Task Force for the current EULAR recommendations on AAV (published in 2023) and of the Task Force for the upcoming EULAR recommendations on GCA, which is currently in progress. He is also a member of the Presidential Council of the European Vasculitis Society (EUVAS).